石家庄以岭药业股份有限公司 关于实际控制人部分股份质押展期的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 石家庄以岭药业股份有限公司（以下简称"公司"或"本公司"）于2025年12月19日接到公司实际控制人吴 瑞的通知，获悉吴瑞所持有本公司的部分股份办理质押展期，具体事项如下： 一、股东部分股份质押展期的基本情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002603 证券简称：以岭药业 公告编号：2025-052 （注：吴相君、吴瑞所持限售股份性质为高管锁定股，故上表中的"已质押股份限售和冻结数量"及"未 质押股份限售和冻结数量"均系高管锁定股。） 吴瑞女士资信状况良好，具备良好的资金偿还能力，质押风险可控，不存在实质性资金偿还风险。上述 质押展期行为不会导致公司实际控制权发生变更、不会对公司生产经营和公司治理产生影响。若出现平 仓风险，吴瑞女士将采取补充质押、提前购回被质押股份等措施应对风险。 二、备查文件 1、广发证券股份有限公司股票质押交易确认书； 2、中国证券登记结算有限责任公司股份冻结明细。 特此公告。 石家庄以岭药业股份 ...

迈为股份公告，公司实际控制人、控股股东之一王正根办理了900万股股份质押展期手续，占其所持股 份比例18.86%，占公司总股本比例3.22%。其中，700万股质押用途为个人资金需求，200万股为补充质 押。质押起始日为2024年12月17日，原质押到期日为2025年12月16日，本次质押展期后到期日为2026年 12月16日，质权人为招商证券股份有限公司。 ...

Core Points - Noli Intelligent Equipment Co., Ltd. announced that its Vice Chairman and Deputy General Manager, Ding Sheng, pledged 4,900,000 shares, which is 37.69% of his holdings and 1.90% of the total shares, with a new pledge expiration date of September 15, 2026 [3] - The controlling shareholder, Ding Yi, along with his associates, holds a total of 91,552,343 shares, representing 35.54% of the total shares, with a cumulative pledge of 18,100,000 shares, which is 19.77% of their total holdings and 7.02% of the total shares [3] - Noli Intelligent Equipment was established on March 3, 2000, with a registered capital of 2,576,007,910 RMB, and its main business includes intelligent manufacturing equipment and smart logistics systems [3] Financial Performance - The company's projected revenues for 2024 and Q2 2025 are 6.979 billion RMB, 1.634 billion RMB, and 3.215 billion RMB, showing year-on-year growth of 0.23%, a decline of 6.69%, and a decline of 7.40% respectively [4] - The net profit attributable to the parent company for the same periods is projected to be 462 million RMB, 123 million RMB, and 246 million RMB, with year-on-year growth rates of 0.91%, 6.30%, and 2.28% respectively [4] - The company's asset-liability ratios for the same periods are 66.27%, 64.62%, and 66.68% [4] Risk Information - The company has a total of 102 internal risks and 219 surrounding risks, with historical risks amounting to 68 and warning risks totaling 222 [4]

Group 1 - The controlling shareholder Shanghai Kangyi has extended the pledge of 5.2 million shares, accounting for 11.00% of its holdings and 3.35% of the company's total share capital [1] - After the pledge extension, Shanghai Kangyi and its concerted parties have cumulatively pledged 10.3352 million shares, representing 21.08% of their holdings and 6.65% of the company's total share capital [1] - The purpose of this pledge extension is to supplement working capital, and there are currently no risks of forced liquidation or transfer [1]

Group 1 - The core point of the announcement is that a major shareholder, Mr. Zhou Zhan, has notified the company about the extension of the pledge on part of his shares [1] - The announcement details the basic situation of the major shareholder's share pledge extension, indicating that there are no significant asset restructuring or performance compensation obligations associated with this pledge [1] - As of the announcement date, Mr. Zhou's personal credit and financial status are reported to be good, and there is no risk of forced liquidation or transfer of the pledged shares [1][2] Group 2 - The company will continue to monitor the pledge situation and associated risks, ensuring timely disclosure of relevant information as required by regulations [1] - The company has outlined measures to address potential risks, such as supplementary pledges or early repurchase of pledged shares, should any liquidation risk arise in the future [1]